R&D
Cell Therapy Deramiocel Slows Arm-Muscle Decline in Advanced Duchenne, Phase 3 Trial Finds
In the 106-patient HOPE-3 trial, boys and young men on deramiocel lost arm and elbow function markedly slower than those on placebo, ahead of an August FDA decision.